
Abstract Objective Management of additional pulmonary blood (APBF) flow during staged palliation toward Fontan completion remains debated, however it may influence long-term outcomes. To assess whether APBF promotes pulmonary artery (PA) growth before Fontan completion and whether different APBF strategies correlate with distinct long-term outcomes. Methods A retrospective single-center study was conducted on 205 patients undergoing Fontan completion between 1989 and 2024. Of these, 98 had APBF (83 antegrade APBF, 15 persistent mBT-shunt). Long-term outcomes included survival and freedom from PA stenting. Results Pre-Fontan PA diameters were larger in patients with APBF than in those without APBF: LPA 10.70 ± 3.76 mm vs 8.80 ± 3.43 mm (p < 0.0001) and RPA 12.18 ± 3.65 mm vs 10.99 ± 3.65 mm (p = 0.032). Within the APBF group, antegrade flow was associated with larger PA diameters than persistent mBT-shunt: LPA 11.12 ± 3.70 mm vs 9.01 ± 3.51 mm (p < 0.0001) and RPA 12.56 ± 3.67 mm vs 11.12 ± 3.59 mm (p = 0.009). Overall survival was higher in patients with APBF at 20 years (97.5% [95% CI, 83.6%–99.6%] vs 88.2% [95% CI, 75.9%–94.4%], p = 0.032). Freedom from PA stenting at 10 years was 98% (95% CI, 81.7%–96.1%) in patients without APBF, 95% (95% CI, 86.3%–98.5%) in those with antegrade APBF, and 78% (95% CI, 45.9%–92.3%) in those with persistent mBT-shunts. Conclusions APBF appears to promote PA growth without increasing pulmonary pressures, but both APBF strategies may be associated with branch PA stenosis, with different timing according to flow type.
Abstract Carinal reconstruction remains technically challenging because of complex airway management and anastomotic tension. A 42-year-old man with adenoid cystic carcinoma extending from the distal trachea to the right main bronchus underwent uniportal robotic-assisted right upper lobectomy and sleeve tracheocarinal resection with pedicled right upper lobe bronchial flap reconstruction under veno-venous extracorporeal membrane oxygenation support. This case suggests that this approach may be technically feasible for selected eccentric, complex tracheocarinal tumors.
OBJECTIVES Patients with acute type A aortic dissection who experience cardiopulmonary arrest require cardiopulmonary resuscitation before definitive repair, but the prognostic relevance of its duration is unclear. We evaluated the association between resuscitation duration and early mortality after emergency surgery. METHODS In this retrospective two-centre study, we included all adults who underwent emergency surgery for acute type A aortic dissection. The exposure was the combined preoperative and intraoperative duration of resuscitation until return of spontaneous circulation or initiation of extracorporeal membrane oxygenation or cardiopulmonary bypass, categorised a priori as none, <15 min or ≥ 15 min. Multilevel proportional hazards models and competing-risks regression, with multiple imputation of missing covariates, were used. RESULTS Of 880 patients, 815 (92.6%), 13 (1.5%), and 52 (5.9%) received no resuscitation, resuscitation for <15 min and resuscitation for ≥15 min, respectively (median recorded duration 29 min, interquartile range 15-43). Thirty-day mortality was 81/815 (9.9%), 3/13 (23.1%) and 42/52 (80.8%), respectively. Resuscitation for ≥15 min was associated with higher 30-day mortality (adjusted hazard ratio 9.59, 95% confidence interval 4.28-21.45; P < 0.001), whereas the estimate for resuscitation for <15 min was imprecise (adjusted hazard ratio 1.68, 95% confidence interval 0.46-6.13; P = 0.43). CONCLUSIONS Among patients selected for emergency surgery for acute type A aortic dissection, combined preoperative and intraoperative resuscitation for ≥15 min was associated with higher 30-day mortality, and the risk increased with resuscitation duration. These findings provide prognostic information rather than a criterion for withholding surgery.
Abstract Objectives Routine repetition of pulmonary function tests (PFTs) following neoadjuvant chemo-immunotherapy is standard but may be redundant in selected patients. We aimed to develop and externally validate a multivariable model to predict post-treatment carbon monoxide lung diffusion capacity (DLCO), with the objective of identifying patients at low predicted risk of clinically important post-treatment impairment in whom selective omission of repeat testing could potentially be considered. Methods A predictive model was derived from 106 patients with locally advanced non-small cell lung cancer (NSCLC) undergoing neoadjuvant chemo-immunotherapy. Multivariable regression with backward stepwise elimination was used to test candidate predictors. The model was validated on an external cohort of 60 patients. Agreement was assessed using locally weighted scatterplot smoothing (Lowess) curves and misclassification rates relative to a clinically relevant threshold of DLCO<60%. Results The final model retained four independent predictors: Baseline DLCO (p < 0.001), Age (p < 0.001), Programmed death-ligand 1 (PD-L1) expression (p = 0.043), and Smoking status (p = 0.10). Applied to the external validation cohort (n = 60), the model demonstrated a median predicted DLCO of 66% (IQR 59-79) versus an observed DLCO of 73% (IQR 59-83), and Lowess curves indicated a stable relationship across the data range. The model correctly identified 100% of patients with an observed post-treatment DLCO<60% by using a predicted threshold of < 65%. All patients with a predicted DLCO>65% had an observed DLCO>60%. Conclusions We developed and externally validated a clinical model that reliably predicts post-neoadjuvant DLCO. The model may help identify asymptomatic patients at low likelihood of a post-treatment DLCO <60% in whom repeat PFT assessment could potentially be omitted. Prospective validation is required before this approach can be recommended in routine clinical practice.
Abstract Objectives To evaluate the feasibility, procedural safety, and clinical outcomes of differentiated intraoperative ventilation strategies tailored to the level and complexity of reconstructive surgery on the tracheal bifurcation and bronchi. Methods A retrospective descriptive institutional study of 1,345 consecutive reconstructive procedures performed between 1986 and 2025 across four specialized thoracic centers by a single surgical team was conducted. Surgeries were categorized into five procedural groups: circumferential carinal resection (n = 142), partial carinal resection (n = 5), bronchial sleeve resection (n = 231), pneumonectomy with stump-less carinal closure (n = 815), and bronchopleural/tracheopleural fistula repair (n = 152). Intraoperative airway management included selective one-lung volume-controlled ventilation (OLV), catheter-based high-frequency jet ventilation (HFJV), and combined/apnoeic techniques. Results No intraoperative deaths occurred, and no complications were directly attributable to ventilation failure. Five transient intraoperative anesthetic incidents occurred in patients with severe cardiopulmonary comorbidities: arterial hypotension (n = 1), supraventricular arrhythmias (n = 2), and asystole/cardiac arrest (n = 2), all successfully resolved. Major postoperative complications occurred in 109 patients (8.1%); 18 patients (1.3%) had complications potentially related to airway management (atelectasis, n = 4; pneumonia, n = 6; acute respiratory distress syndrome, n = 8). Overall 30-day mortality was 0.9% (13/1,345). Mortality was 0% in isolated bronchial resections (0/231), 2.1% after circumferential carinal resection (3/142), 1.3% in post-pneumonectomy fistula repairs (2/152), and 0.98% in stump-less carinal closures (8/815). Conclusions A procedure-tailored ventilation strategy provides safe and reliable intraoperative gas exchange. For carinal reconstructions, catheter-based HFJV is technically advantageous by avoiding bulky tubes in the operative field. For isolated bronchial sleeve resections, conventional selective OLV is sufficient. Managing post-pneumonectomy fistulas requires adaptable maneuvers to maintain gas exchange during induction and airway transection.